ConductScience.org, home

Paper17570410

Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.

Hong SK and 4 others. J Urol, 2007. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. Papers, record 17570410. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17570410

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.
PubMed
Journal
J Urol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2018-12-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hong SKSung Kyu
2Han BKByung Kyu
3Jeong SJSeong Jin
4Byun SSSeok-Soo
5Lee SESang Eun

Source PubMed

Download CSV of authors

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Erectile DysfunctionMajor topic
Heptanoic AcidsMajor topic
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
MicrosurgeryMajor topic
Peripheral NervesMajor topic
Postoperative ComplicationsMajor topic
ProstateMajor topic
ProstatectomyMajor topic
Prostatic NeoplasmsMajor topic
PyrrolesMajor topic
3',5'-Cyclic-GMP Phosphodiesterases
Aged
Atorvastatin
Cyclic Nucleotide Phosphodiesterases, Type 5
Denervation
Drug Therapy, Combination
Follow-Up Studies
Humans
Male
Middle Aged
Penile Erection
Piperazines
Prospective Studies
Purines
Sildenafil Citrate
Sulfones
Vasodilator Agents

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
39194738Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39194738PubMed
35215263Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35215263PubMed
33532301
Generating comprehensive comparative evidence on various interventions for penile rehabilitation in patients with erectile dysfunction after radical prostatectomy: a systematic review and network meta-analysis.
Transl Androl Urol2021https://conductscience.org/library/papers/33532301PubMed
33099581Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis.Int J Impot Res2022https://conductscience.org/library/papers/33099581PubMed
27779230The current evidence on statin use and prostate cancer prevention: are we there yet?Nat Rev Urol2017https://conductscience.org/library/papers/27779230PubMed
26976244Erection rehabilitation following prostatectomy--current strategies and future directions.Nat Rev Urol2016https://conductscience.org/library/papers/26976244PubMed
26816720Current rehabilitation strategy: clinical evidence for erection recovery after radical prostatectomy.Transl Androl Urol2013https://conductscience.org/library/papers/26816720PubMed
24277655Are there any benefits from statin treatment for the septic patient?Curr Atheroscler Rep2014https://conductscience.org/library/papers/24277655PubMed
21716297The effect of simvastatin in penile erection: a randomized, double-blind, placebo-controlled clinical trial (Simvastatin treatment for erectile dysfunction-STED TRIAL).Int J Impot Res2011https://conductscience.org/library/papers/21716297PubMed
19865092Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.Int J Impot Res2010https://conductscience.org/library/papers/19865092PubMed
18784845Overview of contemporary penile rehabilitation therapies.Adv Urol2008https://conductscience.org/library/papers/18784845PubMed
18765112Rationale for statins in the chemoprevention of prostate cancer.Curr Urol Rep2008https://conductscience.org/library/papers/18765112PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDE5A8654PubTator's text mininghttps://conductscience.org/library/genes/8654

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17570410

GET https://conductscience.org/api/papers/v1/17570410/authors